Extending the limits of rehabilitation--opportunities for the physical therapist

Multiple Sclerosis and Seizures: Clinical, Diagnostic and Therapeutic Correlations.

Brain and behavior·2025

A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol.

Clinical lung cancer·2024

Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

COVID-19 Stroke Apical Lung Examination Study 2: a national prospective CTA biomarker study of the lung apices, in patients presenting with suspected acute stroke (COVID SALES 2).

NeuroImage. Clinical·2024

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Pre-processing Applied to Instrumental Data in Analytical Chemistry: A Brief Review of the Methods and Examples.

Critical reviews in analytical chemistry·2023

Let's do it! Fully embrace movement as our identity.

Physical therapy·2026

Generative Artificial Intelligence Use in United States Doctor of Physical Therapy Programs.

Physical therapy·2026

Movement matters: the path to professional impact.

Physical therapy·2026

Sustained Three-Year Impact of a Physical Therapy Quality Improvement Project in the Medical Intensive Care Unit.

Physical therapy·2026

Association Between the Short Physical Performance Battery and Hospitalization-Associated Disability in Older Patients With Heart Failure.

Physical therapy·2026

REmotely monitored, Mobile health-supported Multidomain Rehabilitation with High Intensity Interval Training for COVID-19 (REMM-HIIT-CoV): Trial Design and Rationale.

Physical therapy·2026

Human T-Cell Leukaemia Virus Type 1-Associated Myelopathy in Patients with Rheumatoid Arthritis: A Case Series Highlighting Functional Disability and Diagnostic Challenges.

Modern rheumatology·2026

Strengthening Pain Resilience Through Mobile Technology: A Randomized Controlled Trial on Pain Intensity and Disability in Chronic Pain Management.

Journal of pain research·2026

Feasibility of a Motor-Cognitive Stepping Training Program During Acute Hospitalization in Patients with Traumatic Brain Injury.

Therapeutics and clinical risk management·2026

Fracture With Dorsal Dislocation of the Trapezoid and Trapezium at the Scaphotrapeziotrapezoidal Joint.

Journal of hand surgery global online·2026

Construct validity of the timed 25-foot walk and robustness of clinical benchmarks in multiple sclerosis: exploratory analyses of TEAMS study.

eNeurologicalSci·2026

Comparative outcomes and complication rates of lower trapezius versus latissimus dorsi tendon transfer for irreparable posterosuperior rotator cuff tears: a systematic review.

JSES reviews, reports, and techniques·2026

Related Experiment Videos

Extending the limits of rehabilitation--opportunities for the physical therapist

Related Concept Videos

Multiple Sclerosis and Seizures: Clinical, Diagnostic and Therapeutic Correlations.

A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol.

Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA.

COVID-19 Stroke Apical Lung Examination Study 2: a national prospective CTA biomarker study of the lung apices, in patients presenting with suspected acute stroke (COVID SALES 2).

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.

Pre-processing Applied to Instrumental Data in Analytical Chemistry: A Brief Review of the Methods and Examples.

Let's do it! Fully embrace movement as our identity.

Generative Artificial Intelligence Use in United States Doctor of Physical Therapy Programs.

Movement matters: the path to professional impact.

Sustained Three-Year Impact of a Physical Therapy Quality Improvement Project in the Medical Intensive Care Unit.

Association Between the Short Physical Performance Battery and Hospitalization-Associated Disability in Older Patients With Heart Failure.

REmotely monitored, Mobile health-supported Multidomain Rehabilitation with High Intensity Interval Training for COVID-19 (REMM-HIIT-CoV): Trial Design and Rationale.

Human T-Cell Leukaemia Virus Type 1-Associated Myelopathy in Patients with Rheumatoid Arthritis: A Case Series Highlighting Functional Disability and Diagnostic Challenges.

Strengthening Pain Resilience Through Mobile Technology: A Randomized Controlled Trial on Pain Intensity and Disability in Chronic Pain Management.

Feasibility of a Motor-Cognitive Stepping Training Program During Acute Hospitalization in Patients with Traumatic Brain Injury.

Fracture With Dorsal Dislocation of the Trapezoid and Trapezium at the Scaphotrapeziotrapezoidal Joint.

Construct validity of the timed 25-foot walk and robustness of clinical benchmarks in multiple sclerosis: exploratory analyses of TEAMS study.

Comparative outcomes and complication rates of lower trapezius versus latissimus dorsi tendon transfer for irreparable posterosuperior rotator cuff tears: a systematic review.

Related Experiment Videos

Extending the limits of rehabilitation--opportunities for the physical therapist

Related Concept Videos

Related Articles